Aims : To identify common molecular pathways that could be future therapeutic targets for idiopathic pulmonary fibrosis (IPF) and lung cancer; to present novel epidemiological and clinical data from real life registries; to describe management and diagnostic evaluation of these patients; to present the need of multidisciplinary assessment between pulmonologists, radiologists, histopathologists, thoracic surgeons and oncologists; to identify complications of therapeutic agents in the field such as immunotherapy; to present the need of increased funding for medical research.